http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000510106-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 1997-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2000-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2000510106-A |
| titleOfInvention | Novel peptides suitable for use in antigen-specific immunosuppressive therapy |
| abstract | (57) [Summary]nThe present invention relates to a peptide consisting of 16 to 55 amino acid residues, comprising the amino acid sequences LVCYYTSWS (SEQ ID NO: 60), FLCTHIIYS (SEQ ID NO: 61), IIYSFANIS (SEQ ID NO: 62), LKTLLSVGG (SEQ ID NO: 63), FIKSVPPFL (SEQ ID NO: 63) No. 64), FDGLDLAWL (SEQ ID NO: 65), LYPGRRDKQ (SEQ ID NO: 66), YDIAKISQH (SEQ ID NO: 67), LDFISIMTY (SEQ ID NO: 68), FISIMTYDF (SEQ ID NO: 69), FRGQEDASP (SEQ ID NO: 70), YAVGYMLRL (SEQ ID NO: 71), MLRLGAPAS (SEQ ID NO: 72), LAYYEICDF (SEQ ID NO: 73), LRGATVHRT (SEQ ID NO: 74), YLKDRQLAG (SEQ ID NO: 75), LAGAMVWAL (SEQ ID NO: 76), VWALDLDDF (SEQ ID NO: 77), or LDLDDFQGS (SEQ ID NO: 78) )). The peptides can be used to treat T cell-mediated destruction of articular cartilage. Administration of pharmaceutical compositions based on these peptides can induce systemic tolerance to self-antigens that are attacked by autoreactive T cells. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006062094-A1 |
| priorityDate | 1996-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.